arrow
J

Jeff Slezak

Kaiser Permanente
H指数:44
被引数:8,866

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Impact of Respiratory Syncytial Virus Undertesting on Estimates of Disease Burden and Vaccine Effectiveness in a Large Integrated Healthcare System

呼吸道合胞病毒检测不足对大型整合医疗系统中疾病负担和疫苗效果估计的影响

2026-09-020
OAAI
Bivalent RSVpreF effectiveness against RSV-associated hospital or emergency department care over two seasons: a retrospective test-negative case control study

双价RSVpreF对两个季节RSV相关住院或急诊就诊的有效性:一项回顾性测试阴性病例对照研究

2026-05-270
OAAI
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season

老年人呼吸道合胞病毒相关急性呼吸道疾病疫苗有效性估计:基于首次上市后季节的研究结果

2025-10-011
OAAI
Respiratory syncytial virus vaccine uptake among adults aged ≥60 years in a large, integrated healthcare system in Southern California 2023-2024

南加州大型整合医疗体系中≥60岁成人呼吸道合胞病毒疫苗接种率(2023-2024)

VACCINE
IF3.5
2025-04-010
PRE
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study

BNT162b2 BA.4/5二价mRNA疫苗对美国大型卫生系统中一系列新型冠状病毒肺炎结果的有效性: 一项测试阴性病例对照研究

2023-12-0123
OAAI